Report cover image

Contact-lens Induced Infection Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 06, 2025
Length 130 Pages
SKU # APRC20261215

Description

Summary

According to APO Research, The global Contact-lens Induced Infection market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Contact-lens Induced Infection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Contact-lens Induced Infection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Contact-lens Induced Infection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Contact-lens Induced Infection include Teva Pharmaceutical, Merck & Co., Pfizer, Alcon, AbbVie, Shionogi, Santen Pharmaceutical, Roche Holding and Otsuka Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contact-lens Induced Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contact-lens Induced Infection.

The Contact-lens Induced Infection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Contact-lens Induced Infection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Contact-lens Induced Infection Segment by Company

Teva Pharmaceutical
Merck & Co.
Pfizer
Alcon
AbbVie
Shionogi
Santen Pharmaceutical
Roche Holding
Otsuka Pharmaceutical
Novartis International
Kowa Company
Hikma Pharmaceuticals
Dr. Reddy’s Laboratories
Bausch + Lomb
AstraZeneca
Contact-lens Induced Infection Segment by Type

Corticosteroids
Anti-inflammatory Drugs
Antibiotics
NSAIDs
Other
Contact-lens Induced Infection Segment by Application

Retail Pharmacy
Ophthalmology Clinics
Hospitals
Other
Contact-lens Induced Infection Segment by Application

Retail Pharmacy
Ophthalmology Clinics
Hospitals
Other
Contact-lens Induced Infection Segment by Region


North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contact-lens Induced Infection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contact-lens Induced Infection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contact-lens Induced Infection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Contact-lens Induced Infection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

130 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Contact-lens Induced Infection by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Corticosteroids
2.2.3 Anti-inflammatory Drugs
2.2.4 Antibiotics
2.2.5 NSAIDs
2.2.6 Other
2.3 Contact-lens Induced Infection by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Retail Pharmacy
2.3.3 Ophthalmology Clinics
2.3.4 Hospitals
2.3.5 Other
2.4 Assumptions and Limitations
3 Contact-lens Induced Infection Breakdown Data by Type
3.1 Global Contact-lens Induced Infection Historic Market Size by Type (2020-2025)
3.2 Global Contact-lens Induced Infection Forecasted Market Size by Type (2026-2031)
4 Contact-lens Induced Infection Breakdown Data by Application
4.1 Global Contact-lens Induced Infection Historic Market Size by Application (2020-2025)
4.2 Global Contact-lens Induced Infection Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Contact-lens Induced Infection Market Perspective (2020-2031)
5.2 Global Contact-lens Induced Infection Growth Trends by Region
5.2.1 Global Contact-lens Induced Infection Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Contact-lens Induced Infection Historic Market Size by Region (2020-2025)
5.2.3 Contact-lens Induced Infection Forecasted Market Size by Region (2026-2031)
5.3 Contact-lens Induced Infection Market Dynamics
5.3.1 Contact-lens Induced Infection Industry Trends
5.3.2 Contact-lens Induced Infection Market Drivers
5.3.3 Contact-lens Induced Infection Market Challenges
5.3.4 Contact-lens Induced Infection Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Contact-lens Induced Infection Players by Revenue
6.1.1 Global Top Contact-lens Induced Infection Players by Revenue (2020-2025)
6.1.2 Global Contact-lens Induced Infection Revenue Market Share by Players (2020-2025)
6.2 Global Contact-lens Induced Infection Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Contact-lens Induced Infection Head Office and Area Served
6.4 Global Contact-lens Induced Infection Players, Product Type & Application
6.5 Global Contact-lens Induced Infection Manufacturers Established Date
6.6 Global Contact-lens Induced Infection Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Contact-lens Induced Infection Market Size (2020-2031)
7.2 North America Contact-lens Induced Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Contact-lens Induced Infection Market Size by Country (2020-2025)
7.4 North America Contact-lens Induced Infection Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Contact-lens Induced Infection Market Size (2020-2031)
8.2 Europe Contact-lens Induced Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Contact-lens Induced Infection Market Size by Country (2020-2025)
8.4 Europe Contact-lens Induced Infection Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Contact-lens Induced Infection Market Size (2020-2031)
9.2 Asia-Pacific Contact-lens Induced Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Contact-lens Induced Infection Market Size by Country (2020-2025)
9.4 Asia-Pacific Contact-lens Induced Infection Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Contact-lens Induced Infection Market Size (2020-2031)
10.2 South America Contact-lens Induced Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Contact-lens Induced Infection Market Size by Country (2020-2025)
10.4 South America Contact-lens Induced Infection Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Contact-lens Induced Infection Market Size (2020-2031)
11.2 Middle East & Africa Contact-lens Induced Infection Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Contact-lens Induced Infection Market Size by Country (2020-2025)
11.4 Middle East & Africa Contact-lens Induced Infection Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Teva Pharmaceutical
12.1.1 Teva Pharmaceutical Company Information
12.1.2 Teva Pharmaceutical Business Overview
12.1.3 Teva Pharmaceutical Revenue in Contact-lens Induced Infection Business (2020-2025)
12.1.4 Teva Pharmaceutical Contact-lens Induced Infection Product Portfolio
12.1.5 Teva Pharmaceutical Recent Developments
12.2 Merck & Co.
12.2.1 Merck & Co. Company Information
12.2.2 Merck & Co. Business Overview
12.2.3 Merck & Co. Revenue in Contact-lens Induced Infection Business (2020-2025)
12.2.4 Merck & Co. Contact-lens Induced Infection Product Portfolio
12.2.5 Merck & Co. Recent Developments
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Revenue in Contact-lens Induced Infection Business (2020-2025)
12.3.4 Pfizer Contact-lens Induced Infection Product Portfolio
12.3.5 Pfizer Recent Developments
12.4 Alcon
12.4.1 Alcon Company Information
12.4.2 Alcon Business Overview
12.4.3 Alcon Revenue in Contact-lens Induced Infection Business (2020-2025)
12.4.4 Alcon Contact-lens Induced Infection Product Portfolio
12.4.5 Alcon Recent Developments
12.5 AbbVie
12.5.1 AbbVie Company Information
12.5.2 AbbVie Business Overview
12.5.3 AbbVie Revenue in Contact-lens Induced Infection Business (2020-2025)
12.5.4 AbbVie Contact-lens Induced Infection Product Portfolio
12.5.5 AbbVie Recent Developments
12.6 Shionogi
12.6.1 Shionogi Company Information
12.6.2 Shionogi Business Overview
12.6.3 Shionogi Revenue in Contact-lens Induced Infection Business (2020-2025)
12.6.4 Shionogi Contact-lens Induced Infection Product Portfolio
12.6.5 Shionogi Recent Developments
12.7 Santen Pharmaceutical
12.7.1 Santen Pharmaceutical Company Information
12.7.2 Santen Pharmaceutical Business Overview
12.7.3 Santen Pharmaceutical Revenue in Contact-lens Induced Infection Business (2020-2025)
12.7.4 Santen Pharmaceutical Contact-lens Induced Infection Product Portfolio
12.7.5 Santen Pharmaceutical Recent Developments
12.8 Roche Holding
12.8.1 Roche Holding Company Information
12.8.2 Roche Holding Business Overview
12.8.3 Roche Holding Revenue in Contact-lens Induced Infection Business (2020-2025)
12.8.4 Roche Holding Contact-lens Induced Infection Product Portfolio
12.8.5 Roche Holding Recent Developments
12.9 Otsuka Pharmaceutical
12.9.1 Otsuka Pharmaceutical Company Information
12.9.2 Otsuka Pharmaceutical Business Overview
12.9.3 Otsuka Pharmaceutical Revenue in Contact-lens Induced Infection Business (2020-2025)
12.9.4 Otsuka Pharmaceutical Contact-lens Induced Infection Product Portfolio
12.9.5 Otsuka Pharmaceutical Recent Developments
12.10 Novartis International
12.10.1 Novartis International Company Information
12.10.2 Novartis International Business Overview
12.10.3 Novartis International Revenue in Contact-lens Induced Infection Business (2020-2025)
12.10.4 Novartis International Contact-lens Induced Infection Product Portfolio
12.10.5 Novartis International Recent Developments
12.11 Kowa Company
12.11.1 Kowa Company Company Information
12.11.2 Kowa Company Business Overview
12.11.3 Kowa Company Revenue in Contact-lens Induced Infection Business (2020-2025)
12.11.4 Kowa Company Contact-lens Induced Infection Product Portfolio
12.11.5 Kowa Company Recent Developments
12.12 Hikma Pharmaceuticals
12.12.1 Hikma Pharmaceuticals Company Information
12.12.2 Hikma Pharmaceuticals Business Overview
12.12.3 Hikma Pharmaceuticals Revenue in Contact-lens Induced Infection Business (2020-2025)
12.12.4 Hikma Pharmaceuticals Contact-lens Induced Infection Product Portfolio
12.12.5 Hikma Pharmaceuticals Recent Developments
12.13 Dr. Reddy’s Laboratories
12.13.1 Dr. Reddy’s Laboratories Company Information
12.13.2 Dr. Reddy’s Laboratories Business Overview
12.13.3 Dr. Reddy’s Laboratories Revenue in Contact-lens Induced Infection Business (2020-2025)
12.13.4 Dr. Reddy’s Laboratories Contact-lens Induced Infection Product Portfolio
12.13.5 Dr. Reddy’s Laboratories Recent Developments
12.14 Bausch + Lomb
12.14.1 Bausch + Lomb Company Information
12.14.2 Bausch + Lomb Business Overview
12.14.3 Bausch + Lomb Revenue in Contact-lens Induced Infection Business (2020-2025)
12.14.4 Bausch + Lomb Contact-lens Induced Infection Product Portfolio
12.14.5 Bausch + Lomb Recent Developments
12.15 AstraZeneca
12.15.1 AstraZeneca Company Information
12.15.2 AstraZeneca Business Overview
12.15.3 AstraZeneca Revenue in Contact-lens Induced Infection Business (2020-2025)
12.15.4 AstraZeneca Contact-lens Induced Infection Product Portfolio
12.15.5 AstraZeneca Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.